Format

Send to

Choose Destination
Hypertens Pregnancy. 2009;28(3):348-59. doi: 10.1080/10641950802601286.

Validation and compliance of a home monitoring device in pregnancy: microlife WatchBP home.

Author information

1
Maternal & Fetal Research Unit, King's College London, London, UK.

Abstract

OBJECTIVE:

To assess the accuracy and patient compliance in using a novel home blood pressure monitoring device in high-risk pregnancy.

METHODS:

Device accuracy was assessed according to the British Hypertension Society protocol in 45 pregnant women, including 15 with preeclampsia. Twenty-one high-risk pregnant women used the device in addition to their antenatal care.

RESULTS:

The device achieved a mean difference +/- SD of 0.4 +/- 7.3/-0.4 +/- 5.5 mmHg (pregnancy) and -2.6 +/- 7.0/0.8 +/- 4.4 mmHg (preeclampsia) for systolic/diastolic pressure. Eighty-one percent of women did at least 6 measurements/day and all women did at least 2 measurements/week.

CONCLUSION:

The Microlife WatchBP Home is accurate for use in pregnancy and increases surveillance in compliant patients.

PMID:
19263287
DOI:
10.1080/10641950802601286
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Taylor & Francis
Loading ...
Support Center